SCHEMBL276879

SCHEMBL276879

CC(C)CC(CC(C)C)C(=O)O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 2/20 0.73
SLC1A2 P43004 2/20 0.73
CPA1 P15085 1/20 0.60
RNPEP Q9H4A4 2/20 0.55
SLC7A5 Q01650 1/20 0.55
LAP3 P28838 2/20 0.52
ANPEP P15144 2/20 0.52
MME P08473 3/20 0.50
SLC1A1 P43005 1/20 0.48
ALDH1A1 P00352 2/20 0.46
CHRM1 P11229 1/20 0.46
AKR1A1 P14550 1/20 0.46
CHRM3 P20309 1/20 0.46
HTR2A P28223 1/20 0.46
HTR2C P28335 1/20 0.46
ADRA1A P35348 1/20 0.46
HRH1 P35367 1/20 0.46
DRD3 P35462 1/20 0.46
SLC6A3 Q01959 1/20 0.46
HDAC1 Q13547 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11764498 0.97 SLC1A3 (0.70) SLC1A3SLC1A2CPA1RNPEPSLC7A5
SCHEMBL15677325 0.89 SLC1A3 (0.61) SLC1A3SLC1A2CPA1RNPEPSLC7A5
SCHEMBL1257700 0.86 SLC1A3 (0.58) SLC1A3SLC1A2CPA1RNPEPSLC7A5
SCHEMBL12191525 0.86 SLC1A3 (0.60) SLC1A3SLC1A2CPA1RNPEPSLC7A5
SCHEMBL807054 0.86 SLC1A3 (0.60) SLC1A3SLC1A2CPA1RNPEPSLC7A5
SCHEMBL322526 0.86 SLC1A3 (0.60) SLC1A3SLC1A2CPA1RNPEPSLC7A5
SCHEMBL1257697 0.86 SLC1A3 (0.58) SLC1A3SLC1A2CPA1RNPEPSLC7A5
SCHEMBL2267129 0.85 SLC1A2 (1.00) SLC1A3SLC1A2SLC7A5SLC1A1
SCHEMBL11809258 0.84 SLC1A3 (0.58) SLC1A3SLC1A2CPA1RNPEPSLC7A5
SCHEMBL2977232 0.84 SLC1A3 (0.56) SLC1A3SLC1A2CPA1RNPEPSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2859069-B1 METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT FERRARA MARCELLO (IT) 2020-10-14 EP claimed
US-9328300-B2 Method, apparatus and chemical products for treating petroleum equipment FERRARA MARCELLO (IT) 2016-05-03 US claimed
EP-2859069-A1 METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT Ferrara, Marcello (IT) 2015-04-15 EP claimed
WO-2013156228-A1 METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT FERRARA MARCELLO (IT) 2013-10-24 WO claimed
US-20130270157-A1 METHOD, APPARATUS AND CHEMICAL PRODUCTS FOR TREATING PETROLEUM EQUIPMENT FERRARA MARCELLO (IT) 2013-10-17 US claimed
CN-113557265-A Polymer composition and single-layer phase difference material 日产化学株式会社 2021-10-26 CN disclosed
WO-2021143999-A1 NEW COALESCING AGENT FOR COATING COMPOSITIONS AND COATING COMPOSITIONS COMPRISING THE SAME RHODIA OPERATIONS (FR) 2021-07-22 WO disclosed
EP-2859069-B1 METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT FERRARA MARCELLO (IT) 2020-10-14 EP disclosed
CN-106010582-B Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element, retardation film and method for producing same, polymer, and diamine JSR株式会社 2020-04-07 CN disclosed
US-10106752-B2 Method, apparatus and chemical products for treating petroleum equipment FERRARA MARCELLO (IT) 2018-10-23 US disclosed
US-20170037327-A1 METHOD, APPARATUS AND CHEMICAL PRODUCTS FOR TREATING PETROLEUM EQUIPMENT FERRARA MARCELLO (IT) 2017-02-09 US disclosed
EP-2439204-B1 HETEROCYCLIC COMPOUND AND HEMATOPOIETIC STEM CELL AMPLIFIER NISSAN CHEMICAL IND LTD (JP) 2017-01-04 EP disclosed
CN-1272105-A Compound containing six-membered rings, processes for their preparation, and their use as medicaments GILEAD SCIENCES INC (US) 2000-11-01 CN disclosed
WO-2000056757-A1 IMMUNOMODULATORY STEROIDS, IN PARTICULAR THE HEMIHYDRATE OF 16.ALPHA.-BROMOEPIANDROSTERONE HOLLIS-EDEN PHARMACEUTICALS, INC. (US) 2000-09-28 WO disclosed
CN-1238762-A Piperidine compounds GILEAD SCIENCES INC (US) 1999-12-15 CN disclosed
EP-0703211-B1 Process for the preparation of unsaturated ethers DEGUSSA (DE) 1999-11-10 EP disclosed
CN-1147813-A Novel compounds, their synthesis and therapeutic use GILEAD SCIENCES INC (US) 1997-04-16 CN disclosed
EP-0703211-A1 Process for the preparation of unsaturated ethers HÜLS AKTIENGESELLSCHAFT (DE) 1996-03-27 EP disclosed
EP-0490221-B1 Method for the production of unsaturated ethers HOECHST AG (DE) 1995-08-09 EP disclosed
EP-0490221-A2 Method for the production of unsaturated ethers HOECHST AKTIENGESELLSCHAFT (DE) 1992-06-17 EP disclosed